Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NATUS MEDICAL INCORPORATED

(NTUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Natus Medical: Q3 Earnings Snapshot

11/04/2021 | 04:04pm EST

PLEASANTON, Calif. (AP) _ Natus Medical Inc. (NTUS) on Thursday reported third-quarter net income of $5.6 million, after reporting a loss in the same period a year earlier.

The Pleasanton, California-based company said it had profit of 16 cents per share. Earnings, adjusted for one-time gains and costs, came to 28 cents per share.

The maker of medical device for newborn care posted revenue of $113.9 million in the period.

For the current quarter ending in December, Natus Medical expects its per-share earnings to range from 41 cents to 46 cents.

The company expects full-year earnings in the range of $1.13 to $1.18 per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTUS at https://www.zacks.com/ap/NTUS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about NATUS MEDICAL INCORPORATED
01/10Natus Medical Boosts Q4, Full-Year Revenue Outlook
MT
01/10NATUS MEDICAL INCORPORATED : Announces Preliminary 2021 Fourth Quarter and Full Year Reven..
PU
01/10Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
AQ
01/10Natus Medical Incorporated Provides Preliminary Revenue Guidance for the Fourth Quarter..
CI
01/07Natus to Participate in the 24th Annual Needham Virtual Growth Conference
AQ
01/03Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February..
AQ
2021Natus Medical Names New CEO
MT
2021NATUS MEDICAL INCORPORATED : Announces Executive Transition - Form 8-K
PU
2021NATUS MEDICAL INC : Financial Statements and Exhibits (form 8-K)
AQ
2021Natus Medical Incorporated Announces Resignation of Jonathan A. Kennedy as President an..
CI
More news
Financials (USD)
Sales 2021 471 M - -
Net income 2021 23,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 33,7x
Yield 2021 -
Capitalization 797 M 797 M -
Capi. / Sales 2021 1,69x
Capi. / Sales 2022 1,64x
Nbr of Employees 1 420
Free-Float -
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 23,60 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Thomas J. Sullivan President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
D. Christopher Chung Chief Medical Officer & VP-Regulatory Affairs
Ivan Pandiyan Senior Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
NATUS MEDICAL INCORPORATED-0.55%797
THERMO FISHER SCIENTIFIC-14.91%223 721
DANAHER CORPORATION-17.57%193 793
INTUITIVE SURGICAL, INC.-26.48%94 361
SIEMENS HEALTHINEERS AG-12.03%73 251
EDWARDS LIFESCIENCES CORPORATION-15.48%68 358